CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-23 | Pamukcu Rifat Director | Conversion · Series A Non-Voting Convertible Preferred Stock | −27,187 | 0 | ||
| 2022-08-23 | Duey Marc Director | Conversion | +4,009,690 | 4,167,589 | ||
| 2022-08-23 | Duey Marc Director | Conversion | +11,610 | 602 | ||
| 2022-08-23 | Duey Marc Director | Conversion · Series A Non-Voting Convertible Preferred Stock | −400,969 | 0 | ||
| 2022-08-23 | Duey Marc Director | Conversion · Series A Non-Voting Convertible Preferred Stock | −1,161 | 0 | ||
| 2022-08-23 | Gilad Oren President, CEO | Conversion | +6,045,100 | 6,375,414 | ||
| 2022-08-23 | Gilad Oren President, CEO | Conversion · Series A Non-Voting Convertible Preferred Stock | −604,510 | 0 | ||
| 2022-07-28 | Seizinger Bernd R. Director | Grant or award | +5,995 | 324,575 | ||
| 2022-07-28 | Seizinger Bernd R. Director | Grant or award · Stock Option (right to Buy) | +29,575 | 29,575 | ||
| 2022-07-28 | SCHADE CHRISTIAN S Director | Grant or award | +32,400 | 259,246 | ||
| 2022-07-28 | SCHADE CHRISTIAN S Director | Grant or award · Stock Option (right to Buy) | +47,600 | 47,600 | ||
| 2022-07-28 | Peters Richard Director | Grant or award | +5,995 | 10,605 | ||
| 2022-07-28 | Peters Richard Director | Grant or award · Stock Option (right to Buy) | +29,575 | 29,575 | ||
| 2022-07-28 | Pamukcu Rifat Director | Grant or award | +5,995 | 7,862 | ||
| 2022-07-28 | Pamukcu Rifat Director | Grant or award · Stock Option (right to Buy) | +29,575 | 29,575 | ||
| 2022-07-28 | Korbel Gregory Alan SVP, Chief Operating Officer | Grant or award | +24,300 | 45,762 | ||
| 2022-07-28 | Korbel Gregory Alan SVP, Chief Operating Officer | Grant or award · Stock Option (right to Buy) | +35,700 | 35,700 | ||
| 2022-07-28 | HENNEMAN JOHN B III Director | Grant or award | +5,995 | 15,605 | ||
| 2022-07-28 | HENNEMAN JOHN B III Director | Grant or award · Stock Option (right to Buy) | +29,575 | 29,575 | ||
| 2022-07-28 | Grissinger Michael Director | Grant or award | +5,995 | 5,995 |
Page 7 of 10 · 197 trades